TAThan Than Aye

Than Than Aye

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Than Than Aye has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Helicobacter pylori Management in ASEAN Countries: The Bangkok II Consensus Report

    by Ratha‐Korn Vilaichone, Duc Trong Quach, Phubordee Bongkotvirawan, Yeong Yeh Lee, Tiing‐Leong Ang, Muhammad Miftahussurur, Ari Fahrial Syam, Rona Marie Lawenko, Than Than Aye, Sengdao Vannarath, et al.

    Background and Aim: Helicobacter pylori infection remains a major cause of gastric cancer, peptic ulcer disease, and dyspepsia‐related morbidity across ASEAN. Since the first Bangkok Consensus Report in 2018, major advances have emerged in epidemiology, antimicrobial resistance, diagnostics, and eradication therapy. The Bangkok II Consensus Report aimed to provide updated evidence‐based recommendations tailored to Southeast Asia. Methods: A multidisciplinary panel from ASEAN and international partner countries updated regional guidance through three working groups covering epidemiology and indications for treatment, diagnostic testing and confirmation of eradication, and treatment strategies. Clinical questions and statements were developed from structured evidence review. Evidence quality and recommendation strength were graded using GRADE, with consensus defined as ≥ 80% agreement. Results: Twenty‐one clinical questions were addressed. The consensus emphasizes that H. pylori remains an important public health problem in ASEAN; eradication is central to gastric cancer prevention and ulcer management; diagnostic tests should be selected according to indication and local availability; 14‐day bismuth quadruple therapy is the preferred empirical first‐line regimen because of high clarithromycin resistance; PCAB‐based regimens are promising alternatives; and posttreatment confirmation of eradication should be routinely performed. Conclusions: The Bangkok II Consensus Report provides regionally relevant recommendations integrating antimicrobial resistance, healthcare disparities, and resource‐adapted strategies across ASEAN, addressing gaps in global guidelines and supporting reduction of H. pylori ‐associated disease, including gastric cancer, across Southeast Asia.

  • Open Access

    Spectrum of Upper Gastrointestinal Diseases in Patients Presenting with Dyspepsia—A First Report from Myanmar

    by Than Than Aye, Thiri Tin, Mya Thida Aye, Thet Mar Win, Aye Mya Mya Kyaw, Khin San Aye, Myint Naychi Tun

    Background: Dyspepsia is associated with a variety of benign and malignant gastrointestinal diseases. The aim of the study was to evaluate the spectrum of upper gastrointestinal endoscopic findings in patients presenting with dyspepsia.Methods: This is a retrospective study on consecutive patients with dyspepsia undergoing upper gastrointestinal endoscopy at the gastroenterology department of Thingangyun General Hospital, University of Medicine 2, Yangon, from January 1, 2017, to December 31, 2019.Results: In this study, 1650 patients were recruited retrospectively. Forty‐nine patients were excluded due to incomplete data entry. There were 883 female (55%) out of 1601 patients. The mean age was 50.5 ± 15.82 years. The endoscopic findings were gastric/duodenal erosion (10.8%), erosive esophagitis (5.1%), duodenal ulcer (3.5%), gastric ulcer (4.4%), gastroesophageal varices (3.49%), esophageal cancer (0.8%), and gastric cancer (5.3%); in which early‐onset gastric cancer contributed for 17.6%. Miscellaneous diagnoses were 4.2%, and findings were normal at 62.5%. Significant endoscopy findings were diagnosed in patients over 45 years of age. Helicobacter pylori infection was found in 40.6% of the total study population, 52% of gastric cancers, 50% of gastric ulcers, 51.2% of duodenal ulcers, and 49.3% of gastric/duodenal erosions.Conclusion: Significant endoscopic findings in dyspeptic patients are frequent in our data. A considerable number of gastric cancer were diagnosed in patients under 45 years of age. H. pylori is prevalent in our dyspepsia population. The age threshold of 40–45 years for both males and females could be reasonable for the use of endoscopy in patients with dyspepsia in our population.


  • APAGE Position Statements on Green and Sustainability in Gastroenterology, Hepatology, and Gastrointestinal Endoscopy

    by Tiing Leong Ang, Dao Viet Hang, James Weiquan Li, Jacky Chiu Leung Ho, Marianne Linley Sy‐Janairo, Raja Affendi Raja Ali, Govind K. Makharia, Sridhar Sundaram, Tanyaporn Chantarojanasiri, Hyun‐Gun Kim, et al.

    Background and Aim: The APAGE Position Statements aimed to provide guidance to healthcare practitioners on clinical practices aligned with climate sustainability.Methods: A taskforce convened by APAGE proposed provisional statements. Twenty‐two gastroenterologists from the Asian Pacific region participated in online voting and consensus was assessed through an anonymized and iterative Delphi process.Results: There were five sections that addressed the rationale for climate action, the importance of adopting principles of waste management, clinical practice, gastrointestinal endoscopy, and issues related to advocacy and research. Sixteen statements achieved consensus and included the following: 1. APAGE recommends adopting prompt measures to reduce the carbon footprint of clinical practice due to the importance of climate action and its health cobenefits. 5. APAGE recommends adherence to professional clinical guidelines to optimize clinical care delivery in gastroenterology and hepatology to avoid the environmental impact of unnecessary procedures and tests. 8. APAGE recommends an emphasis on health promotion, disease prevention, and appropriate screening and surveillance, when resources are available, to reduce the environmental impact of managing more advanced diseases that require more intensive resources. 12. APAGE recommends that technological advances in endoscopic imaging and artificial intelligence, when available, be used to improve the precision of endoscopic diagnosis to reduce the risk of missed lesions and need for unnecessary biopsies. 13. APAGE recommends against the routine use of single‐use endoscopes.Conclusion: The position statements provide guidance to healthcare practitioners on clinical practices in gastroenterology, hepatology, and endoscopy that promote climate sustainability.


  • Real‐world practice of Helicobacter pylori management: A survey among physicians in Southeast Asia

    by Duc Trong Quach, Ratha‐Korn Vilaichone, Mai Ngoc Luu, Yeong Yeh Lee, Tiing Leong Ang, Muhammad Miftahussurur, Than Than Aye, Dewi Norwani Basir, Ky Vutha, Sengdao Vannarath, et al.

    Background: Multidrug‐resistant Helicobacter pylori strains are emerging in Southeast Asia. This study evaluates the region's real‐world practice in H. pylori management.Materials and Methods: Physicians who managed H. pylori eradication in daily practice across 10 Southeast Asian countries were invited to participate in an online questionnaire, which included questions about the local availability of antimicrobial susceptibility tests (ASTs) and their preferred eradication regimens in real‐world practice. An empiric regimen was considered inappropriate if it did not follow the local guidelines/consensus, particularly if it contained antibiotics with a high reported resistance rate or was recommended not to be empirically used worldwide.Results: There were 564 valid responses, including 314 (55.7%) from gastroenterologists (GIs) and 250 (44.3%) from non‐GI physicians. ASTs were unavailable in 41.7%. In countries with low and intermediate clarithromycin resistance, the most common first‐line regimen was PAC (proton pump inhibitor [PPI], amoxicillin, clarithromycin) (72.7% and 73.2%, respectively). Regarding second‐line therapy, the most common regimen was bismuth‐based quadruple therapy, PBMT (PPI, bismuth, metronidazole, tetracycline) (50.0% and 59.8%, respectively), if other regimens were used as first‐line treatment. Concomitant therapy (PPI, amoxicillin, clarithromycin, metronidazole) (30.5% and 25.9%, respectively) and PAL (PPI, amoxicillin, levofloxacin) (22.7% and 27.7%, respectively) were favored if PBMT had been used as first‐line treatment. In countries with high clarithromycin resistance, the most common first‐line regimen was PBMT, but the utilization rate was only 57.7%. Alarmingly, PAC was prescribed in 27.8% of patients, ranking as the second most common regimen, and its prescription rate was higher in non‐GI physicians than GI physicians (40.1% vs. 16.2%, p < 0.001).Conclusions: Choosing inappropriate regimens containing antibiotics with high resistance rates is not uncommon in Southeast Asia, especially among non‐GI physicians. In countries with high clarithromycin resistance, the PBMT regimen is underutilized.


  • Open Access

    Efficacy of international web‐based educational intervention in the detection of high‐risk flat and depressed colorectal lesions higher (CATCH project) with a video: Randomized trial

    by Mineo Iwatate, Daizen Hirata, Carlos Paolo D. Francisco, Jonard Tan Co, Jeong‐Sik Byeon, Neeraj Joshi, Rupa Banerjee, Duc Trong Quach, Than Than Aye, Han‐Mo Chiu, et al.

    Objectives: Three subcategories of high‐risk flat and depressed lesions (FDLs), laterally spreading tumors non‐granular type (LST‐NG), depressed lesions, and large sessile serrated lesions (SSLs), are highly attributable to post‐colonoscopy colorectal cancer (CRC). Efficient and organized educational programs on detecting high‐risk FDLs are lacking. We aimed to explore whether a web‐based educational intervention with training on FIND clues (fold deformation, intensive stool/mucus attachment, no vessel visibility, and demarcated reddish area) may improve the ability to detect high‐risk FDLs.Methods: This was an international web‐based randomized control trial that enrolled non‐expert endoscopists in 13 Asian countries. The participants were randomized into either education or non‐education group. All participants took the pre‐test and post‐test to read 60 endoscopic images (40 high‐risk FDLs, five polypoid, 15 no lesions) and answered whether there was a lesion. Only the education group received a self‐education program (video and training questions and answers) between the tests. The primary outcome was a detection rate of high‐risk FDLs.Results: In total, 284 participants were randomized. After excluding non‐responders, the final data analyses were based on 139 participants in the education group and 130 in the non‐education group. The detection rate of high‐risk FDLs in the education group significantly improved by 14.7% (66.6–81.3%) compared with −0.8% (70.8–70.0%) in the non‐education group. Similarly, the detection rate of LST‐NG, depressed lesions, and large SSLs significantly increased only in the education group by 12.7%, 12.0%, and 21.6%, respectively.Conclusion: Short self‐education focusing on detecting high‐risk FDLs was effective for Asian non‐expert endoscopists. (UMIN000042348).


  • Open Access

    Diffuse Large B Cell Lymphoma with Cutaneous and Gastrointestinal Involvement

    by Aye-Mya-Mya Kyaw, Than-Than Aye, Lin-Lin Htun

    Diffuse large B cell lymphoma (DLBCL) is the histological subtype of non-Hodgkins lymphoma, representing approximately 30. The most common primary extranodal sites of DLBCL are the gastrointestinal (GI) tract, the head and neck, and the skin/soft tissue. We report a case of DLBCL with cutaneous involvement presenting with skin nodules and GI manifestations such as obstructive jaundice and upper GI bleeding. Malignant cystic pancreatic tumor occupying the head and body with invasion to lower end of common bile duct and periampullary region causing biliary obstruction and mesenteric lymphadenopathy were found in abdominal computed tomography and endoscopic ultrasonography. There was also a large gastric ulcer (Forrest IIa) at the greater curvature of body of the stomach. Histopathological results of the skin and stomach were consistent with diffuse large B cell lymphoma; gastric biopsy being negative for leucocyte common antigen. The patient was considered to have disseminated DLBCL. The aim of the present case report was to present the clinical, radiological, and histological characteristics of the patient, which may aid physicians in diagnosing involvement of multiple extranodal sites in DLBCL.


  • Open Access

    Diagnostic accuracy of serum pepsinogens for atrophic gastritis in Myanmar

    by Myint N. Tun, Khin S. Aye, Than T. Aye


  • Open Access

    Biliary stent placement without endoscopic sphincterotomy in patients with common bile duct stones

    by Aye‐Mya‐Mya Kyaw, Than‐Than Aye, Khin‐San Aye, Wai‐Phyo Aung, Thet‐Mar Win

  • Open Access

    Gastric precancerous conditions in patients with chronic dyspepsia

    by Thet‐Mar Win, Khin‐San Aye, Than‐Than Aye

    Introduction Gastric cancer (GC) is one of the most lethal malignancies worldwide despite decrease in incidence [1]. Helicobacter pylori is positively associated with gastric precancerous conditions [2]. Detection of these conditions, namely atrophic gastritis (AG) and intestinal metaplasia (IM), and their association with H. pylori infection is important for further detection and reduction of overall cancer incidence. Aim To detect the prevalence of H.pylori infection and gastric precancerous conditions in patients with chronic dyspepsia by High Definition White Light Endoscopy (HD-WLE) and Narrow Band Imaging with Magnifying Endoscopy (NBI-ME) Methods This was hospital based descriptive study including chronic dyspeptic patients aged over 50 years. H. pylori infection was diagnosed by rapid urease test. AG and IM were detected by endoscopy (HD-WLE and NBI-ME) and confirmed by histology. Detection rates of each method were compared. Results Total 143 patients (55M/88F) with mean age 64.57 ± 9.957 years were included. H. pylori infection rate was 53.84% (n=77). Twenty two patients with AG (44.9 % of patients with atrophy) and 37.84% (14/37) of patients with IM have H. pylori infection. There was statistical significant difference in detection rates between HD-WLE and NBI-ME for IM (p-0.001) but not for AG (p-0.250). Conclusion H. pylori infection is still high in Myanmar. There were significant associations between H. pylori and gastric precancerous lesions. Detection of atrophic gastritis and intestinal metaplasia by routine usage of NBI-ME along with test and treat H. pylori infection are the strategies to reduce incidence of gastric cancer.


  • Open Access

    Levofloxacin‐based Helicobacter pylori eradication in chronic dyspepsia

    by Wai Phyo Aung, Than Than Aye, Khin San Aye, Aye Mya Mya Kyaw

    Introduction Helicobacter pylori infection in dyspepsia is an important clinical problem with increasing antibiotic resistance. Aim To evaluate the efficacy of levofloxacin based triple therapy compared with clarithromycin based triple therapy for Helicobacter pylori eradication in chronic dyspepsia Methods This was a prospective, single blinded randomized trial. Rapid urease test and histology were performed in patients with chronic dyspepsia who underwent gastroscopy. Helicobacter pylori infected patients were randomly allocated into two equal groups prescribing 10 day course of levofloxacin based or clarithromycin based regime. Endoscopic responses and eradication status of both regimes were rechecked with gastroscopy 4 weeks after therapies. Result 291 treatment-naïve patients were enrolled. Eradication rates were 40% vs 47.5% on intention to treat (ITT) analysis and 43.7% vs 50.8% on per-protocol (PP) for clarithromycin group vs. levofloxacin group, respectively. In levofloxacin arm, eradication occurred in 62.5% (ITT) & 71.4% (PP) of ulcer dyspepsia and 43.2% (ITT) and 46.6% (PP) of non-ulcer dyspepsia. Among ulcer dyspepsia, 58.3% healed in clarithromycin group and 64.3% in levofloxacin group. In non-ulcer dyspepsia, gastritis was resolved in 21% of clarithromycin group and 10% of levofloxacin group. Adverse effects occurred in 30% of clarithromycin group and 27.6% of levofloxacin group. Conclusion In the study, eradication rates of both therapies were very low to unacceptable level. Levofloxacin was not effective in both ulcer and non-ulcer dyspepsia. Emergence of primary levofloxacin resistant strains due to widespread usages in various infections might be the reason.